Objective response after immune checkpoint inhibitors in a chemotherapy-refractory pMMR/MSS metastatic rectal cancer patient primed with experimental AlloStim® immunotherapy.

Autor: Hirschfeld, Ariel, Gurell, Daniel, Har-Noy, Michael
Zdroj: Translational Medicine Communications; 5/14/2024, Vol. 9 Issue 1, p1-11, 11p
Databáze: Complementary Index
Externí odkaz: